Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma

Abstract

Non-Hodgkin lymphoma (NHL) has been associated with immunological defects, chronic inflammatory and autoimmune conditions. Given the link between immune dysfunction and NHL, genetic variants in toll-like receptors (TLRs) have been regarded as potential predictive factors of susceptibility to NHL. Adequate anti-tumoral responses are known to depend on TLR9 function, such that the use of its synthetic ligand is being targeted as a therapeutic strategy. We investigated the association between the functional rs5743836 polymorphism in the TLR9 promoter and risk for B-cell NHL and its major subtypes in three independent case–control association studies from Portugal (1160 controls, 797 patients), Italy (468 controls, 494 patients) and the US (972 controls, 868 patients). We found that the rs5743836 polymorphism was significantly overtransmitted in both Portuguese (odds ratio (OR), 1.85; P=7.3E−9) and Italian (OR, 1.84; P=6.0E−5) and not in the US cohort of NHL patients. Moreover, the increased transcriptional activity of TLR9 in mononuclear cells from patients harboring rs5743836 further supports a functional effect of this polymorphism on NHL susceptibility in a population-dependent manner.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Parkin DM . Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533–543.

    Article  CAS  Google Scholar 

  2. Grulich AE, Vajdic CM, Cozen W . Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 405–408.

    Article  CAS  Google Scholar 

  3. Smedby KE, Askling J, Mariette X, Baecklund E . Autoimmune and inflammatory disorders and risk of malignant lymphomas—an update. J Intern Med 2008; 264: 514–527.

    Article  CAS  Google Scholar 

  4. Kawai T, Akira S . The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373–384.

    Article  CAS  Google Scholar 

  5. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A . The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 2003; 102: 956–963.

    Article  Google Scholar 

  6. Berrington WR, Hawn TR . Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunol Rev 2007; 219: 167–186.

    Article  CAS  Google Scholar 

  7. Carvalho A, Cunha C, Carotti A, Aloisi T, Guarrera O, Di Ianni M et al. Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. Exp Hematol 2009; 37: 1022–1029.

    Article  CAS  Google Scholar 

  8. Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F . Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 2008; 197: 618–621.

    Article  CAS  Google Scholar 

  9. Ng MT, Van’t Hof R, Crockett JC, Hope ME, Berry S, Thomson J et al. Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun 2010; 78: 1345–1352.

    Article  CAS  Google Scholar 

  10. Pine SO, McElrath MJ, Bochud PY . Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS 2009; 23: 2387–2395.

    Article  CAS  Google Scholar 

  11. Marshak-Rothstein A . Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006; 6: 823–835.

    Article  CAS  Google Scholar 

  12. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449: 564–569.

    Article  CAS  Google Scholar 

  13. Jahrsdorfer B, Muhlenhoff L, Blackwell SE, Wagner M, Poeck H, Hartmann E et al. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides. Clin Cancer Res 2005; 11: 1490–1499.

    Article  CAS  Google Scholar 

  14. Hong J, Leung E, Fraser AG, Merriman TR, Vishnu P, Krissansen GW . TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J Gastroenterol Hepatol 2007; 22: 1760–1766.

    Article  CAS  Google Scholar 

  15. Lachheb J, Dhifallah IB, Chelbi H, Hamzaoui K, Hamzaoui A . Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children. Tissue Antigens 2008; 71: 417–425.

    Article  CAS  Google Scholar 

  16. Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 2003; 81: 85–91.

    Article  CAS  Google Scholar 

  17. Mollaki V, Georgiadis T, Tassidou A, Ioannou M, Daniil Z, Koutsokera A et al. Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study. J Hum Genet 2009; 54: 655–659.

    Article  CAS  Google Scholar 

  18. Torok HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C . Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 2004; 127: 365–366.

    Article  Google Scholar 

  19. Ivanovski M, Silvestri F, Pozzato G, Anand S, Mazzaro C, Burrone OR et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998; 91: 2433–2442.

    CAS  PubMed  Google Scholar 

  20. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M . Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005; 84: 1–12.

    Article  Google Scholar 

  21. Pagano JS . Viruses and lymphomas. N Engl J Med 2002; 347: 78–79.

    Article  Google Scholar 

  22. Schollkopf C, Melbye M, Munksgaard L, Smedby KE, Rostgaard K, Glimelius B et al. Borrelia infection and risk of non-Hodgkin lymphoma. Blood 2008; 111: 5524–5529.

    Article  CAS  Google Scholar 

  23. Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007; 110: 4455–4463.

    Article  CAS  Google Scholar 

  24. Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350: 239–248.

    Article  CAS  Google Scholar 

  25. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG . Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175–1176.

    Article  CAS  Google Scholar 

  26. Yamamoto K . Pathogenesis of Sjogren's syndrome. Autoimmun Rev 2003; 2: 13–18.

    Article  Google Scholar 

  27. Skibola CF, Bracci PM, Halperin E, Conde L, Craig DW, Agana L et al. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet 2009; 41: 873–875.

    Article  CAS  Google Scholar 

  28. Hamann L, Glaeser C, Hamprecht A, Gross M, Gomma A, Schumann RR . Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin Chim Acta 2006; 364: 303–307.

    Article  CAS  Google Scholar 

  29. Lammers KM, Ouburg S, Morre SA, Crusius JB, Gionchett P, Rizzello F et al. Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis. World J Gastroenterol 2005; 11: 7323–7329.

    Article  CAS  Google Scholar 

  30. Keinan A, Mullikin JC, Patterson N, Reich D . Measurement of the human allele frequency spectrum demonstrates greater genetic drift in East Asians than in Europeans. Nat Genet 2007; 39: 1251–1255.

    Article  CAS  Google Scholar 

  31. Skibola CF, Curry JD, Nieters A . Genetic susceptibility to lymphoma. Haematologica 2007; 92: 960–969.

    Article  CAS  Google Scholar 

  32. Lange NE, Zhou X, Lasky-Su J, Himes BE, Lazarus R, Soto-Quiros M et al. Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes. BMC Med Genet 2011; 12: 26.

    Article  CAS  Google Scholar 

  33. Novak N, Yu CF, Bussmann C, Maintz L, Peng WM, Hart J et al. Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 2007; 62: 766–772.

    Article  CAS  Google Scholar 

  34. Akira S, Takeda K, Kaisho T . Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675–680.

    Article  CAS  Google Scholar 

  35. Karin M, Cao Y, Greten FR, Li ZW . NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301–310.

    Article  CAS  Google Scholar 

  36. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374: 546–549.

    Article  CAS  Google Scholar 

  37. Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR et al. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells. Blood 2010; 115: 5041–5052.

    Article  CAS  Google Scholar 

  38. Skibola CF, Bracci PM, Halperin E, Nieters A, Hubbard A, Paynter RA et al. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. PLoS One 2008; 3: e2816.

    Article  Google Scholar 

  39. Carvalho A, Marques A, Maciel P, Rodrigues F . Study of disease-relevant polymorphisms in the TLR4 and TLR9 genes: a novel method applied to the analysis of the Portuguese population. Mol Cell Probes 2007; 21: 316–320.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

AC, NSO, MTC and AJA were financially supported by a fellowship from Fundação para a Ciência e Tecnologia, Portugal. MS is a Ciência 2007 fellow. This study was supported by Fundação para a Ciência e Tecnologia, Portugal (PIC/IC/83313/2007) and by Fundação Calouste Gulbenkian, Serviço de Saúde e Desenvolvimento Humano, Portugal (Grant Number:Proc/60666-MM/734). CFS, PB and LC were supported by National Institutes of Health (NIH) grants CA122663 and CA104682, and PB also by NIH grants CA45614 and CA89745. We are grateful to Paulo Vieira, Cecília Leão, Manuel T Silva, Nuno Sousa, Jorge Correia-Pinto, Joana Palha, Margarida Correia-Neves, Margarida Lima and Matthew Berry for all their input throughout these studies and critical reading of the manuscript. We are grateful to the patients who joint this study, as well as to all members of the Life and Health Sciences Research Institute and School of Health Sciences, University of Minho, who contributed in any way to the development of this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F Rodrigues.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carvalho, A., Cunha, C., Almeida, A. et al. The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma. Genes Immun 13, 197–201 (2012). https://doi.org/10.1038/gene.2011.59

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gene.2011.59

Keywords

This article is cited by

Search

Quick links